ASAndré Silva de Sousa

André Silva de Sousa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


André Silva de Sousa has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of Gluten-Free Diet in Non-Celiac Hashimoto’s Thyroiditis: A Systematic Review and Meta-Analysis

    by Edilene Maria Queiroz Araújo, Claubert Radamés Oliveira Coutinho-Lima, André Silva de Sousa, Lana Mércia Santiago de Souza, Helton Estrela Ramos, Bianca de Almeida-Pititto, Graziela De Luca Canto, Virginia Fernandes Moça Trevisani

    Background/Objectives: The gluten-free diet (GFD) may be anti-inflammatory in treating Hashimoto’s thyroiditis (HT), but the studies are inconsistent. Methods: To determine the effects of the GFD in non-celiac HT, we included randomized controlled trials from the following databases: Cochrane Central, Embase, Lilacs, Medline, Scopus, and Web of Science. The study was registered at Prospero (no. CRD42024566034). The outcomes assessed included free triiodothyronine (fT3), free tetraiodothyronine (fT4), thyroid stimulating hormone (TSH), Anti-thyroid Peroxidase (TPO), anti-thyroglobulin (Tg), C-reactive protein (CRP), body weight (BW), body mass index (BMI) and adverse effects. Sensitivity, subgroup, meta-regression, bias risk, and evidence analyses’ certainty were also assessed. Results: Only three studies were meta-analyzed, comprising 110 participants. The pooled data revealed the evidence was very uncertain about the effect of GFD compared to the control group on mean differences (MD) of TSH (MD −0.63 uIU/mL; 95% CI −1.63 to 0.36; p = 0.21), fT3 (MD −0.18 pg/mL; 95% CI −0.50 to 0.14; p = 0.28), fT4 (MD −0.33 ng/dL; 95% CI −0.89 to 0.23; p = 0.24), anti-Tg (MD −10.07 IU/mL; 95% CI −17.73 to −2.42; p = 0.010), anti-TPO (MD 76.19 IU/mL; 95% CI 46.86 to 108.51; p < 0.00001), CRP (MD −0.12 IU/mL; 95% CI −0.30 to 0.07), BW (MD −1.46 kg; 95% CI −6.70 to 3.77), and BMI (MD −1.80 kg/m2; 95% CI −3.30 to −0.31). The quality of evidence was rated as having serious methodological concerns to extremely serious imprecision. Conclusions: The GFD decreased anti-Tg and increased the anti-TPO levels, both significantly. There were no significant results on fT3, fT4, and TSH.


  • Open Access

    Effects of Gluten-Free Diet in Non-Celiac Hashimoto’s Thyroiditis: A Systematic Review and Meta-Analysis

    by Edilene Maria Queiroz Araújo, Claubert Radamés Oliveira Coutinho-Lima, André Silva de Sousa, Lana Mércia Santiago de Souza, Helton Estrela Ramos, Bianca de Almeida-Pititto, Graziela De Luca Canto, Virginia Fernandes Moça Trevisani

    Background/Objectives: The gluten-free diet (GFD) may be anti-inflammatory in treating Hashimoto's thyroiditis (HT), but the studies are inconsistent. To determine the effects of the GFD in non-celiac HT. Methods: We included randomized controlled trials from the following databases: Cochrane Central, Embase, Lilacs, Medline, Scopus, and Web of Science. It was registered at Prospero (no. CRD42024566034). The outcomes assessed included free triiodothyronine (fT3), free tetraiodothyronine (fT4), Thyroid stimulating hormone (TSH), Anti-thyroid Peroxidase (TPO), anti-thyroglobulin (Tg), C-reactive protein (CRP), body weight (BW), body mass index (BMI) and adverse effects. Sensitivity, subgroup, meta-regression, bias risk, and evidence analyses' certainty were also conducted. Results: Only three studies were meta-analyzed, comprising 110 participants. The pooled data revealed the evidence was very uncertain about the effect of GFD compared to the control group on mean differences (MD) of: TSH (MD -0.63 uIU/mL; 95% CI -1.63 to 0.36; p= 0.21), fT3 (MD -0.18 pg/mL; 95% CI -0.50 to 0.14; p= 0.28), fT4(MD -0.33 ng/dL; 95% CI -0.89 to 0.23; p= 0.24), anti-Tg (MD -10.07 IU/mL; 95% CI -17.73 to -2.42; p= 0.010), anti-TPO (MD 76.19 IU/mL; 95% CI 46.86 to 108.51; p< 0.00001), CRP (MD -0.12 IU/mL; 95% CI -0.30 to 0.07), BW (MD -1.46 kg; 95% CI -6.70 to 3.77), BMI (MD -1.80 kg/m2; 95% CI -3.30 to -0.31). The quality of evidence was rated as serious methodological concerns to extremely serious imprecision. Conclusion: The GFD decreased Anti-Tg and increased the Anti-TPO levels, both significantly. There were no significant results on fT3, fT4, and TSH.